Table 2.
HRs (95%CIs) of CKD and ESRD associated with baseline lung function.
| Outcome | PRISm | AO | ||||
|---|---|---|---|---|---|---|
| Model1 HR [95%CI] |
Model2 HR [95%CI] |
Model3 HR [95%CI] |
Model1 HR [95%CI] |
Model2 HR [95%CI] |
Model3 HR [95%CI] |
|
| CKD | 1.59[1.50–1.69]* | 1.29[1.22–1.38]* | 1.20[1.07–1.34]* | 1.18[1.11–1.27]* | 1.19[1.12–1.27]* | 1.17[1.10–1.26]* |
| ESRD | 1.75[1.21–2.53]* | 1.62[1.11–2.34]* | 1.51[1.04–2.19]* | 1.94[1.34–2.81]* | 1.68[1.16–2.45]* | 1.66[1.14–2.42]* |
Model 1: Age, Gender, Race, AHI, Education; Model 2: Model 1 + BMI, smoking status, alcohol drinking frequency; Model 3: Model 2 + Diabetes(self), Hypertension(self), cardiovascular diseases (self), Hyperlipidemia (self); * statistically significant (p-value ≤ 0.05); PRISm, preserved ratio impaired spirometry; AO, airflow obstruction; CKD, chronic kidney disease; ESRD, end-stage renal disease.